Product review · Updated September 30, 2026
Clean & Clear spot-treatment review: NEW FORMULA belongs to a different gel record
A fragrance-free July 2025 gel and a legacy Advantage lotion have different declarations, names and one-day panel claims.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Clean & Clear’s product page still uses the Advantage Acne Spot Treatment name. The newer US label instead identifies Acne Spot Treatment, describes a gel and places NEW FORMULA on its panel. That is a consequential distinction for a whole-formula review: the older Advantage record calls the preparation a lotion and includes fragrance in a longer inactive declaration.
The manufacturer page and two distinct posted labeling records were examined on September 30, 2026. They support a comparison of names, formulas and claims, while leaving the exact website-to-package relationship unresolved. The current gel’s one-day wording is not the older panel’s percentage-of-people statement. No supplied tube, test report or personal skin response was assessed, and the review offers no spot-treatment routine.
In this article
The website still introduces Advantage
The official product page describes Advantage Acne Spot Treatment as a clear formula, with witch hazel discussed for its soothing properties. It also markets the formula as free of oils, dyes, parabens and phthalates. The returned page does not provide a complete ingredient declaration or identify the product by the newer label’s NDC. Manufacturer page.
That gap makes the naming comparison worth keeping. It does not prove that every Advantage page describes an obsolete tube or that the newer tube is absent from stores. The Clinique gel review is another reading about closely related product names, without transferring a formula or result between them.
The July label identifies a NEW FORMULA gel
The July 28, 2025 Kenvue record identifies Acne Spot Treatment, NDC 69968-0804, with salicylic acid 2% and an acne-treatment purpose. Its structured description says gel. The principal panel supplies the NEW FORMULA wording, a 22-milliliter tube description and fragrance-free and oil-free claims. Newer label.
Those particulars give the gel its own identity. A strength shared with another record does not make their full declarations interchangeable. The format guide considers why the product form and purpose matter beside a familiar active, without providing instructions for converting or substituting treatments.
Fragrance-free accompanies a changed inactive list
The newer narrative begins with water, alcohol denat. and witch-hazel water. It also names glycerin, sodium hydroxide, xanthan gum and other inactives. Fragrance is not named in this current narrative, and the panel expressly describes the product as fragrance free. That is a bounded agreement between two parts of the same label. Gel declaration and panel.
A fragrance-free claim should remain that specific claim. The record does not establish that the gel cannot feel drying or irritating to someone. Its warnings still describe increased irritation and dryness with another topical acne medicine; the ingredient list does not cancel that caution. A separate flammability caution also appears in the gel’s warnings. That field does not measure texture or tolerance; it is another part of this exact medicated record that should remain visible beside the fragrance-free headline.
The legacy record says lotion and names fragrance
The separate Advantage record was updated November 6, 2024 and uses NDC 69968-0126. Kenvue appears in the packager and labeler fields, while the narrative still names Johnson & Johnson Consumer Inc as distributor. Its structured product description says lotion. Those distinctions are present in the posted record rather than reconstructed from branding history. Legacy label.
Its full inactive narrative includes fragrance, cyclopentasiloxane and a different set of plant extracts and other constituents. This is not the July gel’s list. The record comparison cannot by itself date a particular shopper’s package or explain the commercial history behind every field.
The one-day headlines are not one identical result
The legacy panel says that 100% of people showed clearer skin in one day and adds a no-overdrying claim. The July gel panel instead carries a clinically-proven-results-in-one-day headline. It does not reproduce the older percentage statement. No underlying report or subject count for the newer headline was available in the examined label. Legacy panel; new gel panel.
These are manufacturer statements attached to different product records. Combining their wording would imply an evidence match that has not been established. Neither panel gives this review a basis for promising a one-day outcome or selecting a clinical winner. Without an examined participant count and report, the older percentage cannot be expanded into a detailed test design. Likewise, clinically proven on the newer panel does not disclose recruitment, comparison conditions or how clearer skin was measured. The two headlines remain distinct attributed claims.
Witch-hazel comfort language has a limited role
The manufacturer attributes a skin-soothing role to naturally sourced witch hazel. Both labels name witch-hazel water, but a shared constituent does not establish that the two complete products have identical comfort results. The ingredient story and the manufacturer’s soothing description are useful information with different evidentiary roles. Product description.
The Kate Somerville review offers a separate discussion of full declarations and comfort wording. The dry-skin guide provides broader context. Neither supplies a missing test for this spot gel or identifies the cause of a reader’s discomfort.
Label flags help keep the version question visible
FDA’s label explanation describes manufacturer changes and special front-label flags, and distinguishes therapeutic purpose, warnings and inactive ingredients. That framework helps explain why the NEW FORMULA panel matters without treating it as a verified match to the website or someone’s tube. FDA explanation.
The original comparison provides further product-role context. The supported account here remains narrow: a specific newer gel with a complete declaration, a distinct legacy lotion and an incompletely matched website heading. Their differences are informative without being turned into a routine, safety clearance or personal recommendation.
Sources behind this reading
- Clean & Clear Advantage Acne Spot Treatment: US product page ↗US manufacturer product record · Checked September 30, 2026
- Clean & Clear Acne Spot Treatment: July 2025 Kenvue NEW FORMULA label ↗Manufacturer-submitted US OTC labeling record · Checked September 30, 2026
- Clean & Clear Advantage Acne Spot Treatment: November 2024 legacy-formula label; Kenvue record/J&J narrative ↗Manufacturer-submitted historical US OTC labeling record; packager and distributor text differ · Checked September 30, 2026
- FDA: The Over-the-Counter Drug Facts Label ↗Regulator explanation of OTC label fields · Checked September 30, 2026